Atlas Trials

Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer

Clinical trial NCT01178944 · COMPLETED

Trial details

NCT number
NCT01178944
Sponsor
Roswell Park Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Undifferentiated CarcinomaGastric AdenocarcinomaGastric Squamous Cell CarcinomaRecurrent Esophageal AdenocarcinomaRecurrent Esophageal Squamous Cell CarcinomaRecurrent Gastric CarcinomaStage IIIB Esophageal AdenocarcinomaStage IIIB Esophageal Squamous Cell CarcinomaStage IIIB Gastric CancerStage IIIC Esophageal AdenocarcinomaStage IIIC Esophageal Squamous Cell Carcinoma
Start date
2010-09-01
Primary completion
2015-01-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.